Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87591 refers to the detection of the infectious agent Neisseria gonorrhoeae through nucleic acid testing, specifically utilizing an amplified probe technique. Neisseria gonorrhoeae is the bacterium responsible for gonorrhea, a prevalent sexually transmitted disease (STD) that can be transmitted through direct sexual contact. This infection can affect various anatomical sites, including the reproductive tract, mouth, throat, eyes, and anus. In many cases, particularly among women, N. gonorrhoeae infections may be asymptomatic, which poses a significant risk as the lack of symptoms can lead to severe complications, including irreversible damage to the reproductive system and potential infertility. Conversely, men typically exhibit symptoms such as burning sensations, itching, and urethral discharge, although they are less likely to experience long-term reproductive damage. The testing process for N. gonorrhoeae often involves the collection of specimens using a swab from affected areas such as the cervix, male urethra, mouth, throat, or eyes. The nucleic acid tests can vary in methodology, with some rapid tests available for use in a physician's office. The amplification technique employed in CPT® Code 87591, such as polymerase chain reaction (PCR) or transcription-mediated amplification (TMA), is particularly useful when the suspected levels of the microorganism in the specimen are low, which may not be detectable through direct probe methods. This amplification allows for the creation of multiple copies of the nucleic acids from N. gonorrhoeae, enhancing the likelihood of detection. The subsequent identification of these nucleic acids can be performed using various detection techniques, providing critical information for diagnosis and treatment management.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 87591 is indicated for the detection of Neisseria gonorrhoeae in patients who may be at risk for gonorrhea infection. The following conditions warrant the use of this testing:

  • Asymptomatic Screening Patients, particularly women, who are asymptomatic but may be at risk for gonorrhea due to sexual exposure.
  • Symptomatic Patients Individuals presenting with symptoms consistent with gonorrhea, such as urethral discharge, burning during urination, or pelvic pain.
  • Contact Tracing Testing individuals who have had sexual contact with a confirmed case of gonorrhea to prevent further transmission.
  • Pregnant Women Screening pregnant women to prevent transmission of the infection to the newborn during delivery.

2. Procedure

The procedure for CPT® Code 87591 involves several key steps to ensure accurate detection of Neisseria gonorrhoeae:

  • Specimen Collection A specimen is collected using a swab from the appropriate anatomical site, which may include the cervix, male urethra, throat, mouth, or eyes, depending on the patient's symptoms and risk factors.
  • Preparation of the Specimen The collected specimen is prepared for testing, which may involve lysing cells to release nucleic acids from the N. gonorrhoeae organism.
  • Amplification of Nucleic Acids An amplification technique, such as polymerase chain reaction (PCR) or transcription-mediated amplification (TMA), is employed to create multiple copies of the nucleic acids from the N. gonorrhoeae present in the specimen. This step is crucial for detecting low levels of the organism.
  • Detection of Nucleic Acids The amplified nucleic acids are then detected using various techniques, which may include fluorescent probes or other methods that allow for the identification of the presence of N. gonorrhoeae.

3. Post-Procedure

After the procedure associated with CPT® Code 87591, the following post-procedure considerations should be noted:

Patients may be advised to await the results of the test, which can vary in turnaround time depending on the laboratory processing the specimen. If the test result is positive, appropriate treatment options will be discussed with the patient, which may include antibiotics to effectively manage the infection. It is also important for patients to inform any sexual partners of the diagnosis to prevent further transmission of the infection. Follow-up testing may be recommended to ensure the effectiveness of the treatment and to confirm that the infection has been cleared. Additionally, patients should be counseled on safe sexual practices to reduce the risk of future infections.

Short Descr N.GONORRHOEAE DNA AMP PROB
Medium Descr IADNA NEISSERIA GONORRHOEAE AMPLIFIED PROBE TQ
Long Descr Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 3
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GZ Item or service expected to be denied as not reasonable and necessary
GW Service not related to the hospice patient's terminal condition
GA Waiver of liability statement issued as required by payer policy, individual case
Q4 Service for ordering/referring physician qualifies as a service exemption
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
33 Preventive services: when the primary purpose of the service is the delivery of an evidence based service in accordance with a us preventive services task force a or b rating in effect and other preventive services identified in preventive services mandates (legislative or regulatory), the service may be identified by adding 33 to the procedure. for separately reported services specifically identified as preventive, the modifier should not be used.
95 Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system.
CR Catastrophe/disaster related
FP Service provided as part of family planning program
GC This service has been performed in part by a resident under the direction of a teaching physician
GX Notice of liability issued, voluntary under payer policy
KX Requirements specified in the medical policy have been met
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
QW Clia waived test
SA Nurse practitioner rendering service in collaboration with a physician
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
Date
Action
Notes
2011-01-01 Changed Short description changed.
1998-01-01 Added First appearance in code book in 1998.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"